NOV 2022 ONCOLOGY CARTOONS .pdf
•
0 likes•222 views
This document provides contact information for Dr. Kanhu Charan Patro, including his medical qualifications and areas of specialization. It also lists his social media profiles on Facebook and SlideShare where he shares oncology cartoons to help educate patients and medical professionals.
Report
Share
Report
Share
Download to read offline
![DR KANHU CHARAN PATRO
M.D, D.N.B[RT], MBA, FICRO, FAROI, PDCR,
CEPC
NOVEMBER 2022 ISSUE/80th VOLUME
www.facebook.com/oncologycartoons/photos_albums
www.slideshare.net/search/slideshow?searchfrom=header&q=oncology+cartoons](https://image.slidesharecdn.com/nov2022-221115013049-58f117d2/85/NOV-2022-ONCOLOGY-CARTOONS-pdf-1-320.jpg)
Recommended
STEREOTAXY EXPERIENCE- SRS.SBRT
SRS/SBRT experience at Maharaja Gandhi Cancer Hospital for the first 50 cases:
- SRS/SBRT uses precisely focused radiation beams to treat tumors with high doses in a single or few fractions while avoiding damage to surrounding tissue.
- Their experience includes cranial and extracranial tumors treated with SRS and SBRT such as brain metastases, meningiomas, pituitary tumors, and tumors in the liver, spine, and lymph nodes.
- Outcomes have been good with response seen on follow up imaging for various tumors including metabolic/structural resolution of treated lesions.
- The hospital is well equipped for SRS/SBRT with a dedicated machine, immobil
2D PLANNING IN BRAIN TUMOR
This document outlines the steps for 2D planning in brain tumor treatment. It describes using a clinical simulator and digitizer to outline the tumor on sequential CT slices using landmarks from a localization image. Points are marked on each slice and connected to generate the tumor contour. Margins are added to create the treatment field. Examples are given of different beam arrangements like parallel opposed pairs and wedge combinations. Quality assurance procedures like checking port films are also discussed. Examples of plans for conditions like pituitary tumors and whole brain radiotherapy are included. The importance of sparing organs at risk is emphasized.
ROSE CASE OF SRS BRAIN METASTASIS
This document summarizes the treatment planning and quality assurance process for single fraction stereotactic radiosurgery (SRS) to treat a brain metastasis in a 70-year old female patient with breast cancer. Key steps included imaging the patient with MRI and CT, delineating the tumor and organs at risk, planning treatment with VMAT to deliver 18Gy in a single fraction, and verifying the plan meets dosimetric parameters including conformality and dose fall-off. A dry run and setup verification using CBCT were performed prior to treatment to ensure accurate dose delivery to the target while sparing surrounding healthy tissue.
Hippocampal sparing whole brain radiation therapy- Making a case!
- A 58-year-old female nurse presented with headache, nausea, and mental status changes. Imaging showed 3 brain metastases with no known primary site.
- She had a KPS of 90, age <60, controlled primary (pending further workup), and no extracranial mets, placing her in RPA class I and GPA group with a predicted median survival of 7.1-11.3 months.
- Treatment options included WBRT alone or WBRT with boost to reduce risk of neurocognitive toxicity based on the RTOG 0933 trial, which showed reduced memory decline with hippocampal avoidance. Patient selection focused on tumor types likely to benefit and survival duration to gain
Prophylactic cranial irradiation
Prophylactic cranial irradiation (PCI) is used to prevent brain metastases in cancers with a high risk of spreading to the brain. It is indicated for small cell lung cancer and certain leukemias. PCI significantly reduces the rate of brain metastases in small cell lung cancer, especially when administered early at higher doses. For extensive stage small cell lung cancer, MRI surveillance may be an alternative to PCI. While PCI reduces brain metastases in leukemia, the risk of brain involvement is low for some types such as AML. The standard dose for PCI is 1200-1800 cGy in fractions, with timing and volumes depending on the cancer type. Potential toxicities include neurocognitive effects, endocrine disorders, and secondary cancers.
SPINE SBRT for beginners
This document provides an overview and practical tips for spine stereotactic body radiation therapy (SBRT). It discusses patient selection criteria including good performance status and life expectancy. Required imaging includes MRI and CT to aid targeting of the gross tumor volume (GTV) and clinical target volume (CTV). Treatment planning considerations include dose selection of 24-35Gy in 3-5 fractions and organ at risk constraints. Delivery involves cone beam CT guidance to ensure accurate positioning. Case studies demonstrate targeting of spinal metastases from different primary cancers. The document emphasizes the importance of immobilization, image guidance and multidisciplinary care for safe and effective spine SBRT.
LUNG SBRT A LITERATURE REVIEW
1. SABR has emerged as an alternative to surgery for medically operable early-stage NSCLC based on case-control studies showing equivalence in outcomes.
2. Randomized trials are still needed to provide level 1 evidence of equivalence since residual differences remain between surgery and SABR cohorts in existing studies.
3. Ongoing trials such as STABLE-MATES, VALOR, and SABRTOOTH aim to address this evidence gap through randomized comparisons of SABR to surgery.
FAST Forward Trial breast cancer
The document discusses the FAST Forward study, a phase III randomized trial comparing different fractionation schedules for adjuvant radiotherapy in breast cancer. The study involved 4096 patients randomized to receive either 40 Gy in 15 fractions, 27 Gy in 5 fractions, or 26 Gy in 5 fractions. At median follow-up of 71.5 months, there was no significant difference in ipsilateral breast tumor recurrence between groups. However, 27 Gy in 5 fractions was associated with significantly increased risk of moderate or marked late normal tissue effects compared to 40 Gy, based on clinical, patient-reported, and photographic assessments. Estimated α/β ratios were 3.7 Gy for tumor control and 1.7 Gy for normal tissue toxicity.
Recommended
STEREOTAXY EXPERIENCE- SRS.SBRT
SRS/SBRT experience at Maharaja Gandhi Cancer Hospital for the first 50 cases:
- SRS/SBRT uses precisely focused radiation beams to treat tumors with high doses in a single or few fractions while avoiding damage to surrounding tissue.
- Their experience includes cranial and extracranial tumors treated with SRS and SBRT such as brain metastases, meningiomas, pituitary tumors, and tumors in the liver, spine, and lymph nodes.
- Outcomes have been good with response seen on follow up imaging for various tumors including metabolic/structural resolution of treated lesions.
- The hospital is well equipped for SRS/SBRT with a dedicated machine, immobil
2D PLANNING IN BRAIN TUMOR
This document outlines the steps for 2D planning in brain tumor treatment. It describes using a clinical simulator and digitizer to outline the tumor on sequential CT slices using landmarks from a localization image. Points are marked on each slice and connected to generate the tumor contour. Margins are added to create the treatment field. Examples are given of different beam arrangements like parallel opposed pairs and wedge combinations. Quality assurance procedures like checking port films are also discussed. Examples of plans for conditions like pituitary tumors and whole brain radiotherapy are included. The importance of sparing organs at risk is emphasized.
ROSE CASE OF SRS BRAIN METASTASIS
This document summarizes the treatment planning and quality assurance process for single fraction stereotactic radiosurgery (SRS) to treat a brain metastasis in a 70-year old female patient with breast cancer. Key steps included imaging the patient with MRI and CT, delineating the tumor and organs at risk, planning treatment with VMAT to deliver 18Gy in a single fraction, and verifying the plan meets dosimetric parameters including conformality and dose fall-off. A dry run and setup verification using CBCT were performed prior to treatment to ensure accurate dose delivery to the target while sparing surrounding healthy tissue.
Hippocampal sparing whole brain radiation therapy- Making a case!
- A 58-year-old female nurse presented with headache, nausea, and mental status changes. Imaging showed 3 brain metastases with no known primary site.
- She had a KPS of 90, age <60, controlled primary (pending further workup), and no extracranial mets, placing her in RPA class I and GPA group with a predicted median survival of 7.1-11.3 months.
- Treatment options included WBRT alone or WBRT with boost to reduce risk of neurocognitive toxicity based on the RTOG 0933 trial, which showed reduced memory decline with hippocampal avoidance. Patient selection focused on tumor types likely to benefit and survival duration to gain
Prophylactic cranial irradiation
Prophylactic cranial irradiation (PCI) is used to prevent brain metastases in cancers with a high risk of spreading to the brain. It is indicated for small cell lung cancer and certain leukemias. PCI significantly reduces the rate of brain metastases in small cell lung cancer, especially when administered early at higher doses. For extensive stage small cell lung cancer, MRI surveillance may be an alternative to PCI. While PCI reduces brain metastases in leukemia, the risk of brain involvement is low for some types such as AML. The standard dose for PCI is 1200-1800 cGy in fractions, with timing and volumes depending on the cancer type. Potential toxicities include neurocognitive effects, endocrine disorders, and secondary cancers.
SPINE SBRT for beginners
This document provides an overview and practical tips for spine stereotactic body radiation therapy (SBRT). It discusses patient selection criteria including good performance status and life expectancy. Required imaging includes MRI and CT to aid targeting of the gross tumor volume (GTV) and clinical target volume (CTV). Treatment planning considerations include dose selection of 24-35Gy in 3-5 fractions and organ at risk constraints. Delivery involves cone beam CT guidance to ensure accurate positioning. Case studies demonstrate targeting of spinal metastases from different primary cancers. The document emphasizes the importance of immobilization, image guidance and multidisciplinary care for safe and effective spine SBRT.
LUNG SBRT A LITERATURE REVIEW
1. SABR has emerged as an alternative to surgery for medically operable early-stage NSCLC based on case-control studies showing equivalence in outcomes.
2. Randomized trials are still needed to provide level 1 evidence of equivalence since residual differences remain between surgery and SABR cohorts in existing studies.
3. Ongoing trials such as STABLE-MATES, VALOR, and SABRTOOTH aim to address this evidence gap through randomized comparisons of SABR to surgery.
FAST Forward Trial breast cancer
The document discusses the FAST Forward study, a phase III randomized trial comparing different fractionation schedules for adjuvant radiotherapy in breast cancer. The study involved 4096 patients randomized to receive either 40 Gy in 15 fractions, 27 Gy in 5 fractions, or 26 Gy in 5 fractions. At median follow-up of 71.5 months, there was no significant difference in ipsilateral breast tumor recurrence between groups. However, 27 Gy in 5 fractions was associated with significantly increased risk of moderate or marked late normal tissue effects compared to 40 Gy, based on clinical, patient-reported, and photographic assessments. Estimated α/β ratios were 3.7 Gy for tumor control and 1.7 Gy for normal tissue toxicity.
Delineation of dysphagia aspiration related structures
Dose to the Dysphagia/Aspiration-Related Structures (DARS) is critical to ensure proper swallowing functions to the patients after IMRT to the head and neck region
Hypofractionation in breast cancer
Hypofractionation in early breast cancer is no more a research scholars topic. Multiple studies with robust data have proven its utility. It may hold an important role in many countries with constrained resources. This is a short presentation incorporating important completed and ongoing trials. Feel free to use this.
SBRT Contouring Guidelines
This document provides contouring and treatment planning guidelines for stereotactic body radiation therapy (SBRT). It discusses indications, contraindications, simulation, target volume delineation, organ at risk contouring, dose prescription, and plan evaluation for SBRT treatment of lung, spine, liver, and other cancers. Key considerations include ensuring accurate tumor targeting given organ motion, minimizing dose to nearby organs at risk, and prescribing ablative doses in a small number of fractions to achieve tumor control.
HOLISTIC APPROACH IN WHOLE BRAIN RADIATION IN BRAIN METS
1. Whole brain radiotherapy is commonly used to treat brain metastases but can cause long-term side effects like memory loss and decreased quality of life.
2. A new study aims to spare structures like the hippocampus, cochlea, and parotid glands using IMRT and VMAT to reduce side effects while maintaining tumor coverage.
3. Dosimetry results found that IMRT and VMAT reduced hippocampal, parotid, and cochlear doses by 45-82% compared to conventional radiotherapy, allowing for improved quality of life.
Radiotherapy advances in Sino-nasal malignancies
1) Sinonasal malignancies are rare tumors involving the nasal cavity and paranasal sinuses. Surgery and radiotherapy are the main treatment modalities.
2) Recent advances have improved survival through more conformal radiation techniques like proton therapy which better spare nearby critical structures.
3) Precision radiotherapy techniques along with chemotherapy have led to improved local control rates for advanced and unresectable tumors.
brachytherapy in carcinoma prostate
brachytherapy in ca prostate.PERMANENT SEED IMPLANT IN PROSTATE CANCER,HDR brachytherapy in ca prostate
RT in Ca esophagus
1. Radiation techniques for treating esophageal cancer include EBRT using 3D-CRT, IMRT, or brachytherapy. IMRT allows for better sparing of organs at risk like the spinal cord, heart, and lungs compared to 3D-CRT.
2. For treatment planning, the gross tumor volume (GTV) and clinical target volume (CTV) must be accurately delineated using imaging like CT, PET, and endoscopy. The CTV includes margins around the GTV to account for microscopic disease.
3. Radiation fields typically cover 3-5cm above and below the tumor with a 2cm radial margin. Enlarged fields covering the whole esophagus
REIRRADIATION FOR BRAIN TUMORS
This document discusses the options and challenges for reirradiating recurrent brain tumors. It may be considered for gliomas or brain metastases if the prior radiation tolerance doses of critical structures like the optic pathways, brainstem and whole brain have not been exceeded. Differentiating tumor recurrence from treatment effects like necrosis or pseudoprogression is important prior to reirradiation. Short interval since prior radiation and large tumor volume predict poor outcomes. With smaller recurrences in favorable locations, reirradiation using techniques like stereotactic radiosurgery may be offered if the radiation interval is over 6 months. A multidisciplinary discussion weighing risks and benefits is needed for each case.
Gynae ONCOLOGY CARTOONS
This document appears to be a publication titled "Oncology Cartoons Gynae Edition" created by Dr. Kanhu Charan Patro in 2020 in Coimbatore, India. It includes Dr. Patro's credentials and specializations in oncology as well as references to spinal stereotactic body radiation therapy volumes, a Facebook page for oncology cartoons, and photos organized by chapter. The publication seems to focus on using cartoons to depict topics in gynaecological oncology.
Lung sbrt ppt
This document discusses lung stereotactic body radiotherapy (SBRT) for the treatment of early stage non-small cell lung cancer (NSCLC). It covers treatment indications for SBRT, methods used to account for tumor motion including 4DCT planning and respiratory gating, treatment planning guidelines, evidence from studies showing high rates of local control and survival, and results from RTOG trials of SBRT for lung cancer. In particular, it highlights that SBRT achieves local control rates of 85-95% and overall survival rates of 50-95% at 3-5 years for early stage NSCLC.
Contouring in breast cancer current practice and future directions
Contouring guidelines for breast cancer radiation therapy aim to define target volumes to adequately treat while minimizing toxicity. The RTOG and ESTRO guidelines provide consensus on contouring clinical target volumes (CTVs) for the breast/chest wall, lymph nodes, and organs at risk. However, some recurrences occur outside these guidelines. A study mapping 243 nodal recurrences found most were within RTOG or ESTRO CTVs, but out-of-field recurrences were often in the lateral and posterior supraclavicular region, particularly for young, triple-negative patients. While contouring guidelines provide standardization, individualized risk assessment may be needed to optimize local control versus toxicity.
Role of SBRT in lung cancer
SBRT is a precise form of radiation therapy that delivers very high ablative doses of radiation to tumors in a small number of fractions. It has become the standard of care for early stage non-small cell lung cancer (NSC LC) that is not surgically resectable. Key aspects of SBRT planning and delivery include delineating targets and organs at risk on imaging, determining appropriate dose and fractionation based on tumor location, using motion management strategies to account for tumor motion, precise daily image guidance, and ensuring dose constraints are met to minimize risks to critical structures like the spinal cord. SBRT provides superior local tumor control compared to conventional fractionation for early stage NSCLC with a favorable toxicity profile.
SPINE SBRT CARTOON
This document provides information about an oncology cartoon series focused on spine stereotactic body radiation therapy (SBRT) created by Dr. Kanhu Charan Patro in 2020. The series includes volume-based chapters that can be found on Dr. Patro's Facebook page for oncology cartoons.
4 D Adaptive Radiotherapy & Tomotherapy
4D radiotherapy aims to adapt treatment plans based on organ and tumor motion over time. This requires 4D data management systems to record treatment delivery and portal images over time. Image processing tools like deformable registration and model-based segmentation can help automate identifying organ motion between 3D scans. Adaptive planning approaches could modify plans at intervals of multiple fractions, daily, or intra-fraction to account for changes. Determining if daily replanning is practical requires considering workload, data management, and the incremental clinical benefits versus costs.
Head and neck reirradiation
This document discusses reirradiation in recurrent head and neck cancer. It notes that radiation therapy plays a central role in head and neck cancer treatment but recurrence still occurs in 20-35% of patients. Reirradiation presents challenges due to prior radiation exposure and damage to normal tissues. The document discusses treatment options, appropriate patient selection, techniques like IMRT to minimize dose to organs at risk, optimal timing and dosing of reirradiation, and management of toxicities.
Radiotherapy in Seminoma
Radiotherapy for Seminoma
- Seminoma accounts for over 60% of testicular germ cell tumors with an incidence of 0.95 per 100,000.
- For stage I seminoma, prophylactic radiation to the para-aortic lymph nodes is the standard of care to reduce the risk of recurrence.
- For stage IIA/IIB seminoma, radiotherapy to the para-aortic, iliac, and inguinal lymph nodes is recommended, with 30Gy to the whole field and a 10Gy boost for stage IIA and 36Gy total for stage IIB.
- Intensity modulated radiation therapy (IMRT) allows for improved sparing of
BOOK ON REIRRADIATION
1. Re-irradiation involves delivering a second course of radiation to patients who develop recurrent or new primary tumors in an area previously treated with radiation. It requires careful patient selection and consideration of normal tissue tolerance to minimize toxicity risks.
2. A multidisciplinary evaluation is necessary to determine if re-irradiation provides a survival or palliative benefit over other treatment options like chemotherapy or surgery. Factors like tumor type, initial treatment details, disease control, and patient performance status must be considered.
3. Advanced radiation techniques like IMRT can help spare nearby organs-at-risk and lower toxicity when used for re-irradiation. Close monitoring during treatment is still needed to watch for normal tissue complications.
image guided brachytherapy carcinoma cervix
IMAGE GUIDED BARCHYTHERAPY
AMERICAN BRACHYTHERAPY GUIDELINES
GEC-ESTRO GUIDELINES
LIMITATIONS OF (2 D)RADIOGRAPHIC IMAGING
VOLUMETRIC IMAGING
ADVANCES
ICRU 89 summary & beyond converted
This is a made easy summary of ICRU 89 guidelines for gynecological brachytherapy. Extra practical questions for MD/DNB Radiotherapy exams are also attached.
MARCH 2023 ONCOLOGY CARTOONS
This document provides summaries of various medical studies, guidelines, and publications related to radiation oncology from March 2023. Topics discussed include delineating and sparing growth plates in pediatric radiation, lung stereotactic body radiation therapy trials, Pentec guidelines on radiation effects in pediatric patients such as hypothyroidism and cardiac toxicity, and radiation therapy for conditions like pterygium and Graves orbitopathy. It also notes that March is Kidney Cancer Awareness Month.
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
More Related Content
What's hot
Delineation of dysphagia aspiration related structures
Dose to the Dysphagia/Aspiration-Related Structures (DARS) is critical to ensure proper swallowing functions to the patients after IMRT to the head and neck region
Hypofractionation in breast cancer
Hypofractionation in early breast cancer is no more a research scholars topic. Multiple studies with robust data have proven its utility. It may hold an important role in many countries with constrained resources. This is a short presentation incorporating important completed and ongoing trials. Feel free to use this.
SBRT Contouring Guidelines
This document provides contouring and treatment planning guidelines for stereotactic body radiation therapy (SBRT). It discusses indications, contraindications, simulation, target volume delineation, organ at risk contouring, dose prescription, and plan evaluation for SBRT treatment of lung, spine, liver, and other cancers. Key considerations include ensuring accurate tumor targeting given organ motion, minimizing dose to nearby organs at risk, and prescribing ablative doses in a small number of fractions to achieve tumor control.
HOLISTIC APPROACH IN WHOLE BRAIN RADIATION IN BRAIN METS
1. Whole brain radiotherapy is commonly used to treat brain metastases but can cause long-term side effects like memory loss and decreased quality of life.
2. A new study aims to spare structures like the hippocampus, cochlea, and parotid glands using IMRT and VMAT to reduce side effects while maintaining tumor coverage.
3. Dosimetry results found that IMRT and VMAT reduced hippocampal, parotid, and cochlear doses by 45-82% compared to conventional radiotherapy, allowing for improved quality of life.
Radiotherapy advances in Sino-nasal malignancies
1) Sinonasal malignancies are rare tumors involving the nasal cavity and paranasal sinuses. Surgery and radiotherapy are the main treatment modalities.
2) Recent advances have improved survival through more conformal radiation techniques like proton therapy which better spare nearby critical structures.
3) Precision radiotherapy techniques along with chemotherapy have led to improved local control rates for advanced and unresectable tumors.
brachytherapy in carcinoma prostate
brachytherapy in ca prostate.PERMANENT SEED IMPLANT IN PROSTATE CANCER,HDR brachytherapy in ca prostate
RT in Ca esophagus
1. Radiation techniques for treating esophageal cancer include EBRT using 3D-CRT, IMRT, or brachytherapy. IMRT allows for better sparing of organs at risk like the spinal cord, heart, and lungs compared to 3D-CRT.
2. For treatment planning, the gross tumor volume (GTV) and clinical target volume (CTV) must be accurately delineated using imaging like CT, PET, and endoscopy. The CTV includes margins around the GTV to account for microscopic disease.
3. Radiation fields typically cover 3-5cm above and below the tumor with a 2cm radial margin. Enlarged fields covering the whole esophagus
REIRRADIATION FOR BRAIN TUMORS
This document discusses the options and challenges for reirradiating recurrent brain tumors. It may be considered for gliomas or brain metastases if the prior radiation tolerance doses of critical structures like the optic pathways, brainstem and whole brain have not been exceeded. Differentiating tumor recurrence from treatment effects like necrosis or pseudoprogression is important prior to reirradiation. Short interval since prior radiation and large tumor volume predict poor outcomes. With smaller recurrences in favorable locations, reirradiation using techniques like stereotactic radiosurgery may be offered if the radiation interval is over 6 months. A multidisciplinary discussion weighing risks and benefits is needed for each case.
Gynae ONCOLOGY CARTOONS
This document appears to be a publication titled "Oncology Cartoons Gynae Edition" created by Dr. Kanhu Charan Patro in 2020 in Coimbatore, India. It includes Dr. Patro's credentials and specializations in oncology as well as references to spinal stereotactic body radiation therapy volumes, a Facebook page for oncology cartoons, and photos organized by chapter. The publication seems to focus on using cartoons to depict topics in gynaecological oncology.
Lung sbrt ppt
This document discusses lung stereotactic body radiotherapy (SBRT) for the treatment of early stage non-small cell lung cancer (NSCLC). It covers treatment indications for SBRT, methods used to account for tumor motion including 4DCT planning and respiratory gating, treatment planning guidelines, evidence from studies showing high rates of local control and survival, and results from RTOG trials of SBRT for lung cancer. In particular, it highlights that SBRT achieves local control rates of 85-95% and overall survival rates of 50-95% at 3-5 years for early stage NSCLC.
Contouring in breast cancer current practice and future directions
Contouring guidelines for breast cancer radiation therapy aim to define target volumes to adequately treat while minimizing toxicity. The RTOG and ESTRO guidelines provide consensus on contouring clinical target volumes (CTVs) for the breast/chest wall, lymph nodes, and organs at risk. However, some recurrences occur outside these guidelines. A study mapping 243 nodal recurrences found most were within RTOG or ESTRO CTVs, but out-of-field recurrences were often in the lateral and posterior supraclavicular region, particularly for young, triple-negative patients. While contouring guidelines provide standardization, individualized risk assessment may be needed to optimize local control versus toxicity.
Role of SBRT in lung cancer
SBRT is a precise form of radiation therapy that delivers very high ablative doses of radiation to tumors in a small number of fractions. It has become the standard of care for early stage non-small cell lung cancer (NSC LC) that is not surgically resectable. Key aspects of SBRT planning and delivery include delineating targets and organs at risk on imaging, determining appropriate dose and fractionation based on tumor location, using motion management strategies to account for tumor motion, precise daily image guidance, and ensuring dose constraints are met to minimize risks to critical structures like the spinal cord. SBRT provides superior local tumor control compared to conventional fractionation for early stage NSCLC with a favorable toxicity profile.
SPINE SBRT CARTOON
This document provides information about an oncology cartoon series focused on spine stereotactic body radiation therapy (SBRT) created by Dr. Kanhu Charan Patro in 2020. The series includes volume-based chapters that can be found on Dr. Patro's Facebook page for oncology cartoons.
4 D Adaptive Radiotherapy & Tomotherapy
4D radiotherapy aims to adapt treatment plans based on organ and tumor motion over time. This requires 4D data management systems to record treatment delivery and portal images over time. Image processing tools like deformable registration and model-based segmentation can help automate identifying organ motion between 3D scans. Adaptive planning approaches could modify plans at intervals of multiple fractions, daily, or intra-fraction to account for changes. Determining if daily replanning is practical requires considering workload, data management, and the incremental clinical benefits versus costs.
Head and neck reirradiation
This document discusses reirradiation in recurrent head and neck cancer. It notes that radiation therapy plays a central role in head and neck cancer treatment but recurrence still occurs in 20-35% of patients. Reirradiation presents challenges due to prior radiation exposure and damage to normal tissues. The document discusses treatment options, appropriate patient selection, techniques like IMRT to minimize dose to organs at risk, optimal timing and dosing of reirradiation, and management of toxicities.
Radiotherapy in Seminoma
Radiotherapy for Seminoma
- Seminoma accounts for over 60% of testicular germ cell tumors with an incidence of 0.95 per 100,000.
- For stage I seminoma, prophylactic radiation to the para-aortic lymph nodes is the standard of care to reduce the risk of recurrence.
- For stage IIA/IIB seminoma, radiotherapy to the para-aortic, iliac, and inguinal lymph nodes is recommended, with 30Gy to the whole field and a 10Gy boost for stage IIA and 36Gy total for stage IIB.
- Intensity modulated radiation therapy (IMRT) allows for improved sparing of
BOOK ON REIRRADIATION
1. Re-irradiation involves delivering a second course of radiation to patients who develop recurrent or new primary tumors in an area previously treated with radiation. It requires careful patient selection and consideration of normal tissue tolerance to minimize toxicity risks.
2. A multidisciplinary evaluation is necessary to determine if re-irradiation provides a survival or palliative benefit over other treatment options like chemotherapy or surgery. Factors like tumor type, initial treatment details, disease control, and patient performance status must be considered.
3. Advanced radiation techniques like IMRT can help spare nearby organs-at-risk and lower toxicity when used for re-irradiation. Close monitoring during treatment is still needed to watch for normal tissue complications.
image guided brachytherapy carcinoma cervix
IMAGE GUIDED BARCHYTHERAPY
AMERICAN BRACHYTHERAPY GUIDELINES
GEC-ESTRO GUIDELINES
LIMITATIONS OF (2 D)RADIOGRAPHIC IMAGING
VOLUMETRIC IMAGING
ADVANCES
ICRU 89 summary & beyond converted
This is a made easy summary of ICRU 89 guidelines for gynecological brachytherapy. Extra practical questions for MD/DNB Radiotherapy exams are also attached.
MARCH 2023 ONCOLOGY CARTOONS
This document provides summaries of various medical studies, guidelines, and publications related to radiation oncology from March 2023. Topics discussed include delineating and sparing growth plates in pediatric radiation, lung stereotactic body radiation therapy trials, Pentec guidelines on radiation effects in pediatric patients such as hypothyroidism and cardiac toxicity, and radiation therapy for conditions like pterygium and Graves orbitopathy. It also notes that March is Kidney Cancer Awareness Month.
What's hot (20)
Delineation of dysphagia aspiration related structures
Delineation of dysphagia aspiration related structures
HOLISTIC APPROACH IN WHOLE BRAIN RADIATION IN BRAIN METS
HOLISTIC APPROACH IN WHOLE BRAIN RADIATION IN BRAIN METS
Contouring in breast cancer current practice and future directions
Contouring in breast cancer current practice and future directions
More from Kanhu Charan
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
This document appears to be a newsletter or e-book with summaries of oncology research articles and case studies from March 2024 to mid-April 2024. It includes summaries on topics like radiotherapy dosing in head and neck cancer, genetic factors in breast cancer treatment, algorithms for surveillance of colorectal polyps, emerging tracers in neuro-oncology, target delineation workflows for various cancer sites, radiation therapy options for pituitary adenoma, comparisons of APBI guidelines for breast cancer, and associations between Chlamydia psittaci and orbital MALT lymphoma. The document also notes that April is National Oral Cancer Awareness Month.
TARGET DELINEATION OF THORACIC NODAL. STATION
The document discusses the different thoracic nodal stations that are relevant for staging lung cancer. It lists 24 different nodal station groups in the thoracic region, including supraclavicular, upper paratracheal, prevertebral, lower paratracheal, subaortic, para aortic, carinal, paraesophageal, and hilar nodal stations. Accurate identification of involved nodal stations is important for determining the stage and treatment planning for lung cancer patients.
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
This document outlines the workflow for target delineation in radiation oncology for carcinoma of the rectum. It defines the gross tumor volume for the primary tumor (GTVp) and involved nodes (GTVn), as well as the clinical target volumes (CTVs) which add margins around the GTVs to cover microscopic disease. It describes the borders of the mesorectum and lists the lymph node regions included in the CTV for involved nodes. It concludes by specifying the planning target volumes (PTVs) which expand the CTVs and listing the dose schedules.
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
1. The document discusses target delineation and radiation therapy workflow for anal cancer, including definitions of gross tumor volume (GTV) and clinical target volumes (CTVs) based on anatomical locations.
2. It provides guidelines for determining margins around the GTV and nearby anatomical structures to create the CTVs for the primary tumor (CTVp), involved nodes (CTVn), and elective nodal regions (CTVnLR) to cover possible microscopic disease.
3. Treatment planning volumes (PTVs) are created by adding margins to the CTVs, with the PTV-HR receiving the full prescription dose and the PTV-LR receiving a lower dose.
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
The document outlines the steps and guidelines for target delineation in vulval cancer radiation therapy planning. It discusses delineating the gross tumor volume (GTV), clinical target volume (CTV), organs at risk (OAR), and planning target volume (PTV). Specific guidelines are provided for contouring depending on the location and extent of the primary tumor, including the vulva, mons pubis, vagina, anorectum, urethra, and clitoris. Radiation dose parameters and OAR constraints are also reviewed. The target delineation workflow aims to adequately cover suspected disease while minimizing dose to surrounding healthy tissues.
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
This document outlines the 10 step workflow for target delineation in cervical cancer radiotherapy treatment planning. It describes the clinical target volumes that should be contoured for the primary gross tumor (GTVp), primary clinical target (CTVp), nodal gross tumor (GTVn), nodal clinical targets (CTVn) and elective nodal volumes. It provides explanations and guidelines for delineating each target volume, including the parametrium and nodal regions. Diagrams and images are included to illustrate the anatomical locations and boundaries of the target volumes.
Oncology cartoons by Dr Kanhu Charan Patro
This document provides guidance on target volume delineation for vulval cancer from the Royal College of Radiologists. It outlines the clinical target volume (CTV) for different disease sites, including the vulva, mons pubis, vagina, anorectum, urethra and pelvic nodes. Contouring workflows and organ-at-risk constraints are also discussed. Recommendations are given for radiation dose and treatment of resectable and unresectable head and neck cancer. The final item notes that smoking increases the risk of kidney cancer.
RADIATION THERAPY IN BILIARY TRACT CANCER
This document provides information on biliary tract cancers and the role of chemoradiotherapy in their treatment. It discusses the anatomy and types of biliary cancers, risk factors, presentation, diagnosis, staging, and standard treatment approaches including surgery. It then focuses on the evidence and guidelines for use of radiation therapy, including as adjuvant therapy after surgery for positive margins or nodes, as radical/definitive therapy for unresectable disease, and for palliation of symptoms from local or metastatic disease. Key findings are that chemoradiation improves local control and survival as adjuvant or radical therapy, and brachytherapy and external beam radiation are effective for palliation. Optimal regimens involve fluorouracil or capec
FEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUME
Dr Kanhu Charan Patro provides summaries of statistical concepts in 3 sentences or less, beginning each summary with the date. Summaries from January 19th to February 15th are presented, covering topics such as p-values, censoring in survival analysis, hazard ratios, and ISRS guidelines for stereotactic radiosurgery. On February 15th, a 3 sentence summary of World Cancer Day is provided, noting the date it is held, the organization that leads it, and the 2024 slogan of "Close the care gap".
Molecular Profile of Endometrial cancer.
The document discusses molecular analysis and classification of endometrial cancer, which impacts staging and treatment decisions. It describes aggressive histological subtypes and how molecular markers like POLE mutations, MMRd, and p53 abnormalities determine low, intermediate, or high risk stratification. Ongoing PORTEC trials are exploring the impact of molecular profiling on adjuvant treatment, with POLE mutations potentially downstaging while p53 mutations upstage disease. Molecular analysis provides predictive significance for personalized adjuvant therapies in endometrial cancer.
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
This document discusses cervical cancer awareness month in January and provides 3 recommendations: 1) Be loyal to your partner to reduce risk of HPV infection, 2) Maintain genital hygiene, 3) Get vaccinated against HPV to prevent cervical cancer, and 4) Get screened regularly to detect cervical cancer early.
TYPES OF STATISTICAL DATA BY DR KANHU CHARAN PATRO
This document discusses types of data in statistics. It defines qualitative and quantitative data, and describes different types of quantitative data like discrete, continuous, ordinal, and nominal. Examples of love and fight data are provided to illustrate these concepts. The document concludes with a short poem about not fighting in marriage.
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
This document discusses stereotactic radiosurgery (SRS) for the treatment of cerebral arteriovenous malformations (AVMs). It begins by explaining what an AVM is and the risks they pose if untreated, such as bleeding in the brain. It then covers treatment options for AVMs and why SRS is often preferred for certain cases, such as when the AVM is in an eloquent or deep brain area. The document provides details on patient selection, imaging and planning for SRS, anticipated outcomes, and risks of treatment complications. It emphasizes the importance of multidisciplinary discussion and informed consent when determining if SRS is appropriate for a patient's individual AVM.
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
1) SBRT is an effective treatment for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT). In a study of 70 HCC patients with PVTT treated with SBRT, median survival was 10 months and 6-month and 12-month survival rates were 67.3% and 40% respectively.
2) Patients who received SBRT combined with transarterial chemoembolization (TACE) had significantly longer survival compared to those who did not receive TACE after SBRT.
3) SBRT is a promising bridging therapy prior to liver transplantation or hepatectomy by downstaging PVTT to make these curative procedures possible.
DR KANHU CHARTAN PATRO/ FOR ENT SURGEONS
1. Radiotherapy plays a crucial role in the treatment of head and neck cancers, both as a primary treatment and in combination with surgery. It is used for cancers of the nasopharynx, larynx, hypopharynx, and as postoperative treatment for most oral cancers.
2. Advances in radiotherapy technology such as IMRT have allowed for better tumor targeting while minimizing doses to surrounding healthy tissues, reducing treatment toxicities. Imaging techniques such as PET-CT provide improved visualization of tumors and affected lymph nodes, helping determine accurate target volumes.
3. Organ preservation approaches using radiotherapy and chemotherapy are increasingly used to treat head and neck cancers, avoiding disfiguring surgeries while achieving high
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
Here are the key points about the hepatitis B vaccine and liver cancer:
- Hepatitis B virus (HBV) infection can lead to chronic hepatitis B and significantly increase the risk of developing liver cancer later in life.
- The hepatitis B vaccine is effective at preventing HBV infection and therefore helps prevent liver cancers caused by the virus. It was the first vaccine referred to as an "anti-cancer" vaccine by the FDA.
- Around 25% of people with chronic HBV infection may develop liver cancer according to the CDC. Getting vaccinated helps avoid this risk.
- The hepatitis B vaccine is available and affordable in India, ranging from around 45 rupees per pediatric dose to 250 rupees for the
More from Kanhu Charan (20)
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
TYPES OF STATISTICAL DATA BY DR KANHU CHARAN PATRO
TYPES OF STATISTICAL DATA BY DR KANHU CHARAN PATRO
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
Recently uploaded
Debunking Nutrition Myths: Separating Fact from Fiction"
In a world overflowing with diet trends and conflicting nutrition advice, it’s easy to get lost in misinformation. This article cuts through the noise to debunk common nutrition myths that may be sabotaging your health goals. From the truth about carbohydrates and fats to the real effects of sugar and artificial sweeteners, we break down what science actually says. Equip yourself with knowledge to make informed decisions about your diet, and learn how to navigate the complexities of modern nutrition with confidence. Say goodbye to food confusion and hello to a healthier you!
Skin Diseases That Happen During Summer.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Public Health Lecture 4 Social Sciences and Public Health
Sociology, Anthropology and Psychology as applied to Public Health
Breast cancer: Post menopausal endocrine therapy
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
All about shoulder Joint ..
All about shoulder joint , Anatomy ,Examination, Special tests and radiology.
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
KENT'S REPERTORY by dr niranjan mohanty.pptx
its a presentation on Dr kents Repertory by Dr niranjan Mohanty
biomechanics of running. Dr.dhwani.pptx
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Ageing, the Elderly, Gerontology and Public Health
Challenges associated with ageing from a public health perspective
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Recently uploaded (20)
Debunking Nutrition Myths: Separating Fact from Fiction"
Debunking Nutrition Myths: Separating Fact from Fiction"
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Public Health Lecture 4 Social Sciences and Public Health
Public Health Lecture 4 Social Sciences and Public Health
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
NOV 2022 ONCOLOGY CARTOONS .pdf
- 1. DR KANHU CHARAN PATRO M.D, D.N.B[RT], MBA, FICRO, FAROI, PDCR, CEPC NOVEMBER 2022 ISSUE/80th VOLUME www.facebook.com/oncologycartoons/photos_albums www.slideshare.net/search/slideshow?searchfrom=header&q=oncology+cartoons